Clinical Trial Update: Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of Zanubrutinib combined with standard chemotherapy for diffuse large B-cell lymphoma is suspended. The study lists CD79A/B gene mutations in it…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Diffuse Large B Cell Lymphoma, CD79A Gene Mutation | Phase 2 | Status: SUSPENDED